This notice of funding opportunity (NOFO) supports the acceleration of a comprehensive HIV prevention, care, and treatment program to achieve HIV epidemic control in selected Health Zones (HZ) in Haut- Katanga province.
Laboratory services, and their networks, are fundamental components of effective, well-functioning health systems and are essential for patient management, disease detection and control, and surveillance. This NOFO will support Mozambique’s Ministry of Health (MOH) to strengthen the integrated national laboratory network in order to ensure the provision of quality services for clinical diagnosis, screening, and surveillance in support of HIV care and treatment and the achievement of an AIDS free generation.
In South Africa, it is estimated that 20% of patients newly initiating anti-retroviral therapy (ART) present late and 10-15% of patients on first line ART are failing treatment, leading to poor retention, especially in the first 12 months of treatment. This NOFO seeks to improve treatment retention and viral load suppression of HIV and TB/HIV co-infected patients through the use of innovative capacity building approaches for health service providers to better manage complicated and unstable HIV and TB/HIV co-infected patients.
This project will have an important role in the attainment of PEPFAR and UNAIDS 95-95-95 goals in the Republic of South Africa. In alignment with World Health Organization (WHO) health system building blocks, activities will reflect the South African National Department of Health’s priorities in human resources for health (HRH), service delivery, information systems, and leadership and governance for sustainable results.
Globally, Tuberculosis (TB) causes one third of all HIV-related deaths. The TB/HIV collaborative activities that decrease TB among PLHIV when combined with ART include TB screening, TB preventive therapy, and TB infection control. In the Central America Region, there is no integration of TB and HIV programs: gaps remain in TB/HIV collaborative activities, registries are incomplete and inaccurate, and many health care workers (HCW) have limited experience in TB/HIV care and treatment.
Zimbabwe has a generalized HIV epidemic with an estimated 1.4 million people living with HIV (PLHIV). Adult prevalence aged 15-49 is 14.0%, down from 18.1% in 2015. Incidence among adults is 0.47%, and the 18-month mother to child transmission (MTCT) rate is 6.74%. However, testing, treatment, and viral suppression coverage all lag behind the 95-95-95 targets. Zimbabwe’s Ministry of Health and Child Care (MOHCC) has highlighted human resource challenges across the continuum of service delivery.
Access to quality assured diagnostics and laboratory services is critical to the effective diagnosis, treatment, and management of HIV and other HIV-related diseases, including TB. Achieving the UNAIDS 95-95-95 targets requires establishment and operationalization of laboratory and diagnostic networks.PEPFAR DRC supported laboratory and integrated diagnostic network strengthening efforts have led to improved access to the quality diagnostic and patient monitoring services. The data reports show improved viral load (VL) coverage from 27% to 56% in FY16 and FY17 and 75% suppression rate.
The CDC seeks qualified applications for a 5-year cooperative agreement to fund HIV prevention, care and treatment, lab support and strategic information and surveillance activities in Burma under the President's Emergency Plan for AIDS Relief (PEPFAR). This NOFO will focus on technical assistance to key partners in country to build capacity for the implementation and monitoring of Test and Start, differentiated ART service delivery models, linkages to care, viral load scale up and quality control systems.
This guide includes WHO recommendations on screening and treatment of pre-cancer lesions and on HPV vaccination made through April 2014, taking account of relevant evidence-based findings published up to December 2013; emerging practices that are still being evaluated are also noted in this publication. This guide, which replaces the 2006 edition, has two new chapters, one newly organized chapter, and two substantially revised chapters. The new chapters include: Essentials for cervical a=cancer prevention and control programmes; and HPV vaccination.